维普期刊资源整合服务平台（V6.5）

98篇 您的检索式：作者名="BRAMLAGE P"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Treatment of peripheral arterial disease using stem and progenitor cell therapy 显示文摘	Lawall H Bramlage P Amann B	2011	J Vase Surg2011，53，2：	1
2	Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease 显示文摘	Bramlage P Swift S L Thoenes M	2016	Eur J Heart Fail2016，18，1：	1
3	Comparison of 3,000 and 5,000 IU aXa/day certoparin in the prevention of deep-vein thrombosis after total hip replacement显示文摘	Bramlage P Michaelis HC Melzer N		0，，01：	1
4	Cost-effectiveness of the artificial liver support system MARS in patients with acute-on-chronic liver failure 显示文摘	Hessel FP Bramlage P Wasem J	2010	Eur J Gastroenteroi Hepatol2010，22，2：	1
5	Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proaf-of-eoncept study显示文摘	Schindler C Mueller A Bramlage P	2007	Angiology2007，58，6：	1
6	Role of the vasodilator peptide angiotensin-( 1-7 ) in cardiovascular drug therapy显示文摘	Schindler C Bramlage P Kirch W Ferrario C M	2007	Vasc Health Risk Manag2007，3，：	1
7	Nephropathy : an overview for daily practice 显示文摘	Pittrow D Wittchen HU Bramlage P	2003	Fortschr Med Orig2003，121，1：	1
8	Diabetes treatment patterns and goal achievement in primary diabetes care ( DiaRegis )-study protocol and patient characteristics at baseline显示文摘	Bramlage P Binz C Gitt AK	2010	Cardiovasc Diabetol2010，53，9：	1
9	Frequency of albuminu- ria in primary care: a cross-sectional study 显示文摘	Bramlage P Pittrow D Lehnert H	2007	Eur J Cardiovasc Prey Rehabil2007，14，1：	1
10	Cost effectiveness of the artificial liver support system MARS in patients with acute on chronic liver failure显示文摘	Hessel FP Bramlage P Wasem J	2010	Eur J Gastroenterol Hepatol2010，22，2：	1
11	Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium显示文摘	BRAMLAGE C P KAPS C UNGETHUM U	2008	Scand J Rheumatol2008，37，6：	1
12	Hypertension in overweight and obese prinmry care patients is highly prevalent and poorly controlled显示文摘	Bramlage P Pittmw D Wittchen H U	2004	Am J Hypertem2004，17，：	1
13	Prevalence of obesity in primary care using different anthropometric measures results of the German Metabolic and Cardiovascular Risk Project(GEMCAS)显示文摘	Hauner H Bramlage P Losch C	2008	BMC Public Health2008，8，：	1
14	Therapeutic Silencing of an Endog e nous Gene by Systemic Administration of Modifi-ed SiRNAs显示文摘	Soutschek J Akinc A Bramlage B Charisse K Constien R Donoghu e M Elba shir S Geick A Hadwiger P Harborth J John M Kesavan V Lavine G Pandey RK Racie T Rajeev KG Rohl I Toudjarska I Wang G Wuschko S Bumcrot D Kotelia nsky V Limmer S Manoharan M Vornlocher		0，，：	1
15	The value of irbesartan in the management of hypertension显示文摘	Bramlage P Durand-Zaleski I Desai N	2009	Ex- pert Opin Pharmacother2009，10，11：	1
16	The value of irbesartan in the management of hypertension显示文摘	Bramlage P Durand-Zaleski I Desai N		0，，11：	1
17	Aotidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients-an analysis &the diaregis registry显示文摘	Tschope D Bramlage P Binz C	2011	Cardiovasc Diabetol2011，10，：	1
18	Significance of initial blood pressure and comorbidity for the efficacy of a fixed combination of an angiotensin receptor blocker and hydrochlorothiazide in clinical practice 显示文摘	Schmieder RE Schwertfeger M Bramlage P	2009	Vase Health Risk Manag2009，，5：	1
19	Hypertension in overweight and obese primary care patiants is highly prevalent and poorly controlled显示文摘	Bramlage P Pittrow D Wittchen HU	2004	Am J Hypertens2004，17，：	1
20	Fixed combination of irbesartan and hydrochlorothiazidein the management of hypertension 显示文摘	Bramlage P	2009	Vase Health Risk Manag2009，5，1：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示